Interview with Professor Kay Davies

Written by Kay Davies

Kay Davies is the Dr Lee’s Professor of Anatomy in the Department of Physiology, Anatomy and Genetics, and Director of the MRC Functional Genomics Unit at the University of Oxford, UK. Her research interests lie in the molecular analysis and development of treatment for human genetic disease, particularly, Duchenne muscular dystrophy (DMD) and the application of genomics for the analysis of neurological disorders and gene–environment interactions. She is co-founder of a company, Summit Therapeutics, which aims to deliver utrophin modulation to the clinic for the therapy of DMD, which currently has a drug in Phase 1 trials. She has published...

To view the full article, please register now for access

It's completely free